©2024 Stanford Medicine
A Study of Genetic Variation Influencing Pain and Response to Opioid Medications
Not Recruiting
Trial ID: NCT01293994
Purpose
The investigators will be collecting saliva DNA samples from chronic back pain patients. The
investigators hope to find candidate genes associated with response to opioid medication by
correlating molecular genetics data with pain measurement and opioid responsiveness data
including opioid hyperalgesia and opioid analgesic tolerance.
Official Title
A Study of Genetic Variation Influencing Pain and Response to Opioid Medications in Patients With Chronic Pain
Stanford Investigator(s)
Lawrence Chu, MD, MS
Professor of Anesthesiology, Perioperative and Pain Medicine
Eligibility
Inclusion Criteria:
1. Adult patient, aged 18-71
2. Recipient of chronic opioid therapy
3. Patient is able to produce a saliva sample
4. If a past study participant, patient will have agreed to be contacted for future
studies.
Exclusion Criteria:
a. not meeting inclusion criteria
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Dan Hoang
6508874677